Transformers Achieve 4× Better Cross-Scanner Generalization Than CNNs: Multi-Center Validation of 3D Swin Transformers Across 1,066 Subjects

Technical Summary: Transformers Achieve 4× Better Cross-Scanner Generalization Than CNNs

Problem Statement
The primary barrier to the clinical deployment of deep learning for medical image segmentation is not achieving high performance on a single dataset, but maintaining that performance when applied to data acquired from different scanners, protocols, and institutions. This "cross-scanner generalization" problem typically manifests as severe performance degradation (8–15%) when Convolutional Neural Networks (CNNs), trained on one scanner, are applied to external datasets from different manufacturers or field strengths. This occurs because CNNs often learn scanner-specific intensity patterns rather than purely anatomical features. While traditional solutions like aggressive harmonization (e.g., ComBat, histogram matching) attempt to artificially reduce these differences during training, they fail to address the fundamental need for models to learn genuinely scanner-invariant features. Furthermore, the extent to which Transformer architectures, with their self-attention mechanisms, can solve this problem compared to CNNs remains largely unquantified in rigorous multi-center settings.

Methodology
The authors present a comprehensive multi-center validation of a hierarchical 3D Swin Transformer for hippocampal segmentation in Alzheimer's disease (AD) research. The study employed a strict "zero-shot" evaluation protocol across 1,066 subjects from three independent datasets:

• Training: ADNI dataset (N=500, Siemens 3T).
• External Validation (Zero-Shot):
  • OASIS (N=235, Siemens 1.5T, different field strength).
  • AIBL (N=331, Multi-vendor 3T: Siemens/Philips/GE).

Key Design Choices:

• Minimal Harmonization: To stress-test the model's ability to learn scanner-invariant features, the authors intentionally avoided aggressive scanner harmonization (no histogram matching, no ComBat correction). Only minimal standardization was applied: brain extraction (HD-BET), bias correction (N4ITK), registration (FSL FLIRT), and Z-score normalization.
• Architecture: A hierarchical 3D Swin Transformer adapted for volumetric segmentation. It utilizes window-based self-attention within local 7³ windows and a multi-task learning objective combining Dice loss (segmentation) and Focal/Cross-Entropy loss (classification) to force the encoder to learn shared, disease-relevant anatomical features.
• Baselines: Performance was compared against standard CNN baselines, specifically U-Net and nnU-Net.
• Validation Metrics: The study utilized the Dice Similarity Coefficient (DSC), Hausdorff Distance (HD), and longitudinal atrophy rate quantification. It also included clinical validation with five radiologists, uncertainty quantification via Monte Carlo dropout, and a 5-fold cross-validation for reproducibility.

Key Contributions

1. First Rigorous Multi-Center Transformer Validation: This is the first study to validate transformer-based medical segmentation across multiple independent centers with truly independent external datasets (different field strengths and vendors) without using them for hyperparameter tuning or model selection.
2. Quantified Superiority Over CNNs: The work provides a head-to-head comparison demonstrating that Transformers achieve 4–7× better cross-scanner generalization than CNNs.
3. Complete Clinical Deployment Package: Beyond algorithmic metrics, the paper provides evidence required for clinical translation, including radiologist agreement studies, longitudinal disease tracking validation, calibrated uncertainty quantification, and systematic failure analysis.
4. Open Multi-Center Benchmark: The authors establish an open benchmark for evaluating cross-scanner generalization, addressing the field's need for standardized multi-center evaluation protocols.

Results

• Generalization Performance: The 3D Swin Transformer achieved a DSC of 0.892±0.003 on the ADNI test set. When applied zero-shot to external datasets, it showed minimal degradation:
  • OASIS (1.5T): DSC 0.871±0.012 (2.1% degradation).
  • AIBL (Multi-vendor): DSC 0.883±0.008 (0.9% degradation).
• Comparison to CNNs: In contrast, CNN baselines (U-Net) exhibited significantly higher degradation: 8.2% on OASIS and 9.7% on AIBL. This represents a 4× to 7.4× improvement in generalization capability for the Transformer.
• Clinical Validation: Five radiologists achieved substantial agreement (Fleiss κ = 0.72) with the model. The model's output was deemed acceptable without modification in 87% of cases, offering a 91.6% reduction in annotation time.
• Longitudinal Analysis: In a 24-month follow-up of 186 subjects, the model successfully tracked disease-specific atrophy rates consistent with clinical progression: Control (CN) at -0.8%/year, Mild Cognitive Impairment (MCI) at -2.1%/year, and Alzheimer's (AD) at -3.2%/year (p<0.001).
• Uncertainty Quantification: Monte Carlo dropout yielded a strong correlation (r=0.907) between prediction uncertainty and segmentation error, correctly flagging 87% of failures.
• Reproducibility: Five-fold cross-validation and independent re-implementation confirmed stable performance (Mean DSC = 0.891±0.003).

Significance and Claims
The paper claims that Transformer architectures fundamentally solve the cross-scanner generalization problem, which has been identified as the critical barrier to multi-center clinical deployment in medical AI. By achieving clinically acceptable performance (DSC > 0.87) across diverse scanners, field strengths, and vendors without fine-tuning, the authors argue that Transformers are the architecture of choice for real-world clinical applications where scanner diversity is unavoidable.

The work asserts that this is not merely an incremental improvement but a qualitative difference: while CNNs fail to generalize across scanners, Transformers maintain robust performance by learning abstract, anatomically meaningful features. The study establishes a new standard for medical imaging deep learning by combining rigorous zero-shot external validation with a complete clinical validation package, thereby advancing the field toward practical, multi-center clinical deployment.